143 related articles for article (PubMed ID: 23625596)
21. Using biomarkers as objective standards in the diagnosis of cervical biopsies.
Galgano MT; Castle PE; Atkins KA; Brix WK; Nassau SR; Stoler MH
Am J Surg Pathol; 2010 Aug; 34(8):1077-87. PubMed ID: 20661011
[TBL] [Abstract][Full Text] [Related]
22. Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological care.
Peres AL; Paz E Silva KM; de Araújo RF; de Lima Filho JL; de Melo Júnior MR; Martins DB; de Pontes Filho NT
J Biomed Sci; 2016 May; 23(1):42. PubMed ID: 27175798
[TBL] [Abstract][Full Text] [Related]
23. [Cervical biopsy: is the histological diagnosis reliable and reproducible? Utility of p16 INK4A in its achievement].
Curiel Valdés Jde J
Ginecol Obstet Mex; 2007 Oct; 75(10):615-20. PubMed ID: 18800580
[TBL] [Abstract][Full Text] [Related]
24. Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis.
Qiao X; Bhuiya TA; Spitzer M
J Low Genit Tract Dis; 2005 Apr; 9(2):100-7. PubMed ID: 15870531
[TBL] [Abstract][Full Text] [Related]
25. BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix.
Badr RE; Walts AE; Chung F; Bose S
Am J Surg Pathol; 2008 Jun; 32(6):899-906. PubMed ID: 18425044
[TBL] [Abstract][Full Text] [Related]
26. Histology of cervical intraepithelial neoplasia and the role of biomarkers.
Martin CM; O'Leary JJ
Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):605-15. PubMed ID: 21636328
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal clinical evaluation of a novel antibody cocktail for detection of high-grade squamous intraepithelial lesions on cervical cytology specimens.
Tambouret RH; Misdraji J; Wilbur DC
Arch Pathol Lab Med; 2008 Jun; 132(6):918-25. PubMed ID: 18517273
[TBL] [Abstract][Full Text] [Related]
28. Interlaboratory concordance of p16/Ki-67 dual-staining interpretation in HPV-positive women in a screening population.
Benevolo M; Mancuso P; Allia E; Gustinucci D; Bulletti S; Cesarini E; Carozzi FM; Confortini M; Bisanzi S; Carlinfante G; Rubino T; Rollo F; Marchi N; Farruggio A; Pusiol T; Venturelli F; Giorgi Rossi P;
Cancer Cytopathol; 2020 May; 128(5):323-332. PubMed ID: 32168431
[TBL] [Abstract][Full Text] [Related]
29. Utility of p16, Ki-67, and HPV test in diagnosis of cervical intraepithelial neoplasia and atrophy in women older than 50 years with 3- to 7-year follow-up.
Jackson JA; Kapur U; Erşahin Ç
Int J Surg Pathol; 2012 Apr; 20(2):146-53. PubMed ID: 22104735
[TBL] [Abstract][Full Text] [Related]
30. [Diagnosis and differential diagnosis of cervical intraepithelial neoplasias and related disease].
Chen J; Chang XY
Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):563-6. PubMed ID: 17980109
[No Abstract] [Full Text] [Related]
31. Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study.
Halloush RA; Akpolat I; Jim Zhai Q; Schwartz MR; Mody DR
Cancer; 2008 Dec; 114(6):474-80. PubMed ID: 19016301
[TBL] [Abstract][Full Text] [Related]
32. Expression of the Immunohistochemical Markers p16 and Ki-67 and Their Usefulness in the Diagnosis of Cervical Intraepithelial Neoplasms.
de Melo FL; Lancellotti CL; da Silva MA
Rev Bras Ginecol Obstet; 2016 Feb; 38(2):82-7. PubMed ID: 26883858
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of p16, human papillomavirus capsid protein L1 and Ki-67 in cervical intraepithelial lesions: potential utility in diagnosis and prognosis.
Alshenawy HA
Pathol Res Pract; 2014 Dec; 210(12):916-21. PubMed ID: 25149503
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic Accuracy of Conventional Cell Blocks Along with p16INK4 and Ki67 Biomarkers as Triage Tests in Resource-poor Organized Cervical Cancer Screening Programs.
Desai F; Singh LS; Majachunglu G; Kamei H
Asian Pac J Cancer Prev; 2019 Mar; 20(3):917-923. PubMed ID: 30912415
[TBL] [Abstract][Full Text] [Related]
35. Potential influence of p16 immunohistochemical staining on the diagnosis of squamous cell lesions in cervical biopsy specimens: observation from cytologic-histologic correlation.
Yang J; Elliott A; Hoffa AL; Herring N; Houser PM
Cancer Cytopathol; 2018 Dec; 126(12):1003-1010. PubMed ID: 30307707
[TBL] [Abstract][Full Text] [Related]
36. Expression of geminin, p16, and Ki67 in cervical intraepithelial neoplasm and normal tissues.
Xing Y; Wang C; Wu J
Medicine (Baltimore); 2017 Jun; 96(26):e7302. PubMed ID: 28658133
[TBL] [Abstract][Full Text] [Related]
37. [Diagnosis and grading of cervical intraepithelial neoplasias].
Rosamilia C; Feichter G; Tzankov A; Obermann EC
Pathologe; 2012 Mar; 33(2):118-23. PubMed ID: 22350168
[TBL] [Abstract][Full Text] [Related]
38. Adjunct p16(INK4a) immunohistochemistry aids the detection of high-grade squamous intraepithelial lesions in endocervical curettage specimens.
Shah AA; Jeffus SK; Zhao Z; Stoler MH; Stelow EB
Am J Clin Pathol; 2014 Mar; 141(3):342-7. PubMed ID: 24515761
[TBL] [Abstract][Full Text] [Related]
39. A pilot evaluation of a novel immunohistochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression (ProEx C) in cervical adenocarcinoma in situ, adenocarcinoma, and benign glandular mimics.
Aximu D; Azad A; Ni R; Colgan T; Nanji S
Int J Gynecol Pathol; 2009 Mar; 28(2):114-9. PubMed ID: 19188825
[TBL] [Abstract][Full Text] [Related]
40. p16INK4a immunohistochemical and histopathologic study of Pap test cases interpreted as HSIL without CIN2-3 identification in subsequent cervical specimens.
Solano FJ; Rush DS; Wilkinson EJ
Int J Gynecol Pathol; 2015 May; 34(3):215-20. PubMed ID: 25844545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
